| Product Code: ETC11392687 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Antiglaucoma Drugs Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Antiglaucoma Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Antiglaucoma Drugs Market - Industry Life Cycle |
3.4 Israel Antiglaucoma Drugs Market - Porter's Five Forces |
3.5 Israel Antiglaucoma Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Israel Antiglaucoma Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Israel Antiglaucoma Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Antiglaucoma Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of glaucoma in Israel |
4.2.2 Growing awareness about eye health and early detection of glaucoma |
4.2.3 Advancements in technology leading to the development of innovative antiglaucoma drugs |
4.3 Market Restraints |
4.3.1 High cost associated with antiglaucoma drugs |
4.3.2 Stringent regulatory requirements for drug approval |
4.3.3 Limited access to healthcare facilities in certain regions of Israel |
5 Israel Antiglaucoma Drugs Market Trends |
6 Israel Antiglaucoma Drugs Market, By Types |
6.1 Israel Antiglaucoma Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Israel Antiglaucoma Drugs Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Israel Antiglaucoma Drugs Market Revenues & Volume, By Prostaglandin Analogs, 2021 - 2031F |
6.1.4 Israel Antiglaucoma Drugs Market Revenues & Volume, By Beta Blockers, 2021 - 2031F |
6.1.5 Israel Antiglaucoma Drugs Market Revenues & Volume, By Carbonic Anhydrase Inhibitors, 2021 - 2031F |
6.2 Israel Antiglaucoma Drugs Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Israel Antiglaucoma Drugs Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Israel Antiglaucoma Drugs Market Revenues & Volume, By Eye Drops, 2021 - 2031F |
6.2.4 Israel Antiglaucoma Drugs Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 Israel Antiglaucoma Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Antiglaucoma Drugs Market Revenues & Volume, By Hospital, 2021 - 2031F |
6.3.3 Israel Antiglaucoma Drugs Market Revenues & Volume, By Retail, 2021 - 2031F |
6.3.4 Israel Antiglaucoma Drugs Market Revenues & Volume, By Online, 2021 - 2031F |
7 Israel Antiglaucoma Drugs Market Import-Export Trade Statistics |
7.1 Israel Antiglaucoma Drugs Market Export to Major Countries |
7.2 Israel Antiglaucoma Drugs Market Imports from Major Countries |
8 Israel Antiglaucoma Drugs Market Key Performance Indicators |
8.1 Number of glaucoma screenings conducted annually |
8.2 Adoption rate of newly launched antiglaucoma drugs in the market |
8.3 Percentage of glaucoma patients under proper treatment and management |
9 Israel Antiglaucoma Drugs Market - Opportunity Assessment |
9.1 Israel Antiglaucoma Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Israel Antiglaucoma Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Israel Antiglaucoma Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Antiglaucoma Drugs Market - Competitive Landscape |
10.1 Israel Antiglaucoma Drugs Market Revenue Share, By Companies, 2024 |
10.2 Israel Antiglaucoma Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here